Prostate Cancer

Cause of Post-RP Death in High-Risk PCa Patients Linked to Age

Cause of Post-RP Death in High-Risk PCa Patients Linked to Age

Within 10 years of surgery, men younger than 60 years are more likely to die from prostate cancer than from other causes.

Return to Full Potency Rare After Prostate Surgery

Return to Full Potency Rare After Prostate Surgery

Only 6.7% of men reported erections that were as good after radical prostatectomy, as before—much lower than would be expected by IIEF-5 scores.

Prostate Cancer Recurrence Risk After Surgery Higher in Smokers

Prostate Cancer Recurrence Risk After Surgery Higher in Smokers

By

Even patients who quit smoking less than 10 years after radical prostatectomy are at increased risk.

Statins Promising for Cancers

Statins Promising for Cancers

By

Studies suggest that these cholesterol-lowering drugs can improve treatment of genitourinary cancers and prevent contrast-induced nephropathy.

Low Testosterone After ADT Linked with Improved Survival

Low Testosterone After ADT Linked with Improved Survival

By

Low serum testosterone levels within the first year of androgen-deprivation therapy (ADT) is associated with improved cause-specific survival.

Factors Affecting Treatment Regret in Prostate Cancer

Factors Affecting Treatment Regret in Prostate Cancer

The researchers found that 12% of the participants experienced treatment decisional regret.

CVD Risk Increased in Patients on Androgen Deprivation Therapy for Prostate Cancer

CVD Risk Increased in Patients on Androgen Deprivation Therapy for Prostate Cancer

Highest risk during first 6 months of ADT among men who had cardiovascular events before treatment.

Fatal Prostate Cancer Not Associated with Vitamin D

Fatal Prostate Cancer Not Associated with Vitamin D

Also, no significant associations found between vitamin D-related SNPs and fatal prostate cancer

Low-Grade Prostate Cancers Rarely Metastasize

Low-Grade Prostate Cancers Rarely Metastasize

By

In a study, not a single case of metastatic disease developed among 449 men who had a tumor grade of Gleason 6 or less at radical prostatectomy.

PCa Family History May Raise Breast Cancer Risks

PCa Family History May Raise Breast Cancer Risks

Doctors should ask women about the medical history of their first-degree male relatives, researchers say

IMRT Used Less in Black Prostate Cancer Patients

IMRT Used Less in Black Prostate Cancer Patients

By

African American patients are less likely than Caucasians to receive intensity-modulated radiation therapy for localized prostate cancer.

Metformin May Reduce Prostate Cancer Recurrence Risk

Metformin May Reduce Prostate Cancer Recurrence Risk

By

Meta-analysis shows that use of medication is associated with an 18% lower risk.

Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa

Low-dose Brachytherapy Provides Better Outcomes in Intermediate PCa

Low-dose-rate brachytherapy boost (LDR-PB) achieves better rates of biochemically disease-free outcomes in prostate cancer.

Nerve Wrap May Hasten Potency Return

Nerve Wrap May Hasten Potency Return

By

The average time to return of continence and potency following prostatectomy was significantly shorter in the allograft than no-allograft group.

Short-Term ADT+Radiotherapy Does Not Help Intermediate PCa Survival

Short-Term ADT+Radiotherapy Does Not Help Intermediate PCa Survival

Adding short-term androgen deprivation therapy to radiotherapy does not improve overall survival in intermediate-risk prostate cancer.

Early Bicalutamide Aids Survival in Nonmetastatic Prostate Cancer

Early Bicalutamide Aids Survival in Nonmetastatic Prostate Cancer

Adding bicalutamide improves overall survival among patients with advanced nonmetastatic hormone-naïve prostate cancer.

Prostate Cancer Active Surveillance Outcomes Vary by Disease Risk

Prostate Cancer Active Surveillance Outcomes Vary by Disease Risk

By

Cancer-specific and overall survival is decreased in men with intermediate-risk versus low-risk tumors.

Statins Plus ADT After Prostate Cancer Radiotherapy Ups Survival

Statins Plus ADT After Prostate Cancer Radiotherapy Ups Survival

By

Researchers observed a significant 36% decreased overall and prostate cancer-specific mortality.

New Tool Could Spare Men Unnecessary Prostate Biopsies

New Tool Could Spare Men Unnecessary Prostate Biopsies

By

The 4Kscore enables better identification of men who harbor high-grade prostate cancer.

Radiation Plus ADT Beneficial in Node-Positive Prostate Cancer

Radiation Plus ADT Beneficial in Node-Positive Prostate Cancer

By

The 5-year risk of overall mortality is decreased by 50% compared with androgen deprivation therapy alone.

Better mCRPC Survival with Docetaxel Followed by Abiraterone

Better mCRPC Survival with Docetaxel Followed by Abiraterone

By

This medication sequence was associated with longer progression-free and overall survival compared with the reverse.

Genitourinary Cancer in Siblings Raises Personal Risk

Genitourinary Cancer in Siblings Raises Personal Risk

By

Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.

Adding Statins to ADT May Delay PCa Progression

Adding Statins to ADT May Delay PCa Progression

By

Prostate cancer progression was delayed by a median 10 months in statin users.

Testicular Cancer May Raise Risk of Prostate Tumors

Testicular Cancer May Raise Risk of Prostate Tumors

By

A history of testicular cancer was associated with a greater likelihood of prostate cancer overall and intermediate- or high-risk disease.

Delaying Prostatectomy Appears Safe for AS Patients

Delaying Prostatectomy Appears Safe for AS Patients

By

No higher risk of adverse pathology among men on active surveillance who delayed surgery until signs of disease progression.

Higher-Risk Prostate Cancer On the Rise

Higher-Risk Prostate Cancer On the Rise

By

The proportion of men diagnosed with intermediate- or high-risk disease rose 6% from 2011 to 2013, study finds.

Suicide Among Genitourinary Cancer Patients

Suicide Among Genitourinary Cancer Patients

Risk factors include male gender, distant disease, increasing age, race/ethnicity

Radiotherapy Common for Prostate Cancer

Radiotherapy Common for Prostate Cancer

Research raises concerns about possible overuse of radiation therapy

Prostatectomy May Impair Sex for Women, Too

Prostatectomy May Impair Sex for Women, Too

Sexual function declines for both men and women following radical prostatectomy, but some aspects of care may help couples.

Increasing Observation of Younger Men with PCa

Increasing Observation of Younger Men with PCa

From 2004 to 2009, there was a marked increase in observation (watchful waiting and active surveillance) among men with low-risk prostate cancer.

Sign Up for Free e-newsletters